Momentum Bioscience
PrivateLast Round
Series A
Dec 1, 2023
Total Funding Raised
$1.13M
Company Overview
Momentum Bioscience operates in Healthcare & Life Sciences and is based in Abingdon. Its latest recorded funding round was a Series A round in December 2023.
Momentum Bioscience is a biotechnology company that develops diagnostic solutions for the rapid detection of bloodstream infections and sepsis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Momentum Bioscience Comparables
Compare Momentum Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HelixBind | 88% | |
| Novus Diagnostics | 84% | |
| Deepull | 81% |
For institutional investors. Book with your work email.
Momentum Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 1, 2023 | ||||
| Grant | Jan 11, 2023 | ||||
| Follow-on Offering | Mar 28, 2012 | ||||
| Seed | Sep 1, 2011 |
For institutional investors. Book with your work email.
Momentum Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Intuitive Investments Group Plc | Series A |
| Newable Private Investing | Seed, Follow-on Offering |
| Development Bank of Wales | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors increased 54% MoM.
- Mar 28, 2012
$770K raised from Anthony Clarke and Newable Private Investing.
For institutional investors. Book with your work email.
Momentum Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Momentum Bioscience's valuation, stock price, and market status.
Is Momentum Bioscience a public or private company?
Momentum Bioscience is a private company.
What is the current stock price of Momentum Bioscience?
Momentum Bioscience is a private company, so its shares have no public market price. Caplight tracks Momentum Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Momentum Bioscience worth (valuation)?
Valuation information for Momentum Bioscience is not publicly available.
Can I buy Momentum Bioscience stock?
Momentum Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Momentum Bioscience's last funding round?
Momentum Bioscience's most recent funding round was Series A on December 1, 2023.
Who are the main investors in Momentum Bioscience?
Key investors in Momentum Bioscience include European Innovation Council Fund, Intuitive Investments Group Plc, Newable Private Investing, Development Bank of Wales.
Will Momentum Bioscience IPO soon?
No public IPO plans have been announced for Momentum Bioscience.
How can I track Momentum Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Momentum Bioscience's shares on secondary markets.